Αποτελέσματα Αναζήτησης
Between September 2009 and June 2010, >350 million doses of vaccine were administered, targeting various populations. As of 6 June 2010, more than 214 countries had reported laboratory-confirmed cases of pandemic A (H1N1) 2009 influenza, including at least 18 156 deaths.
60 Minutes Correspondent Scott Pelley tours the Sanofi Pasteur plant in Swiftwater, Pa., the only one in America making the H1N1 flu vaccine.
7 Μαΐ 2020 · What was more readily available, at least in the Southern Hemisphere in 2009, was the 2009 seasonal inactivated influenza vaccine containing the seasonal A(H1N1) virus, that was later found to have modest efficacy against the A(H1N1)pdm09 virus (38% (95% CI: 19%, 53%)) .
17 Δεκ 2009 · We conducted a single-center study, involving 176 adults, 18 to 50 years of age, to test the monovalent influenza A/California/2009 (H1N1) surface-antigen vaccine, in both MF59-adjuvanted...
17 Δεκ 2009 · A split-virus, inactivated candidate vaccine against the 2009 H1N1 virus was manufactured, and we evaluated its safety and immunogenicity in a randomized clinical trial.
4 vaccines against 2009 H1N1 influenza approved by FDA. Healthy adults and older children found to need 1 dose of vaccine to generate strong immune response; children under 9 need two doses. Influenza activity peaks the second week of the month. October: 3 million doses of nasal spray are the first vaccine ready for distribution
1 Οκτ 2016 · Case-control studies demonstrated that monovalent 2009 H1N1 vaccines were effective in preventing infection with the 2009 H1N1 virus, but preliminary data suggests that it is important for individuals to be re-immunized annually.
